316 related articles for article (PubMed ID: 29286008)
61. Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients.
Falagas ME; Rafailidis PI; Matthaiou DK; Virtzili S; Nikita D; Michalopoulos A
Int J Antimicrob Agents; 2008 Nov; 32(5):450-4. PubMed ID: 18768302
[TBL] [Abstract][Full Text] [Related]
62. Microbiology and prevalence of E
de la Cruz-Hernández I; Cornejo-Juárez P; Tellez-Miranda O; Barrera-Pérez L; Sandoval-Hernández S; Vilar-Compte D; Velázquez-Acosta C; Volkow P
Am J Infect Control; 2020 Jan; 48(1):40-45. PubMed ID: 31395288
[TBL] [Abstract][Full Text] [Related]
63. Mutant prevention concentrations of colistin for Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae clinical isolates.
Choi MJ; Ko KS
J Antimicrob Chemother; 2014 Jan; 69(1):275-7. PubMed ID: 23997018
[No Abstract] [Full Text] [Related]
64. Innate Immune Signaling Activated by MDR Bacteria in the Airway.
Parker D; Ahn D; Cohen T; Prince A
Physiol Rev; 2016 Jan; 96(1):19-53. PubMed ID: 26582515
[TBL] [Abstract][Full Text] [Related]
65. Distribution of biocide resistant genes and biocides susceptibility in multidrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii - A first report from the Kingdom of Saudi Arabia.
Vijayakumar R; Sandle T; Al-Aboody MS; AlFonaisan MK; Alturaiki W; Mickymaray S; Premanathan M; Alsagaby SA
J Infect Public Health; 2018; 11(6):812-816. PubMed ID: 29907439
[TBL] [Abstract][Full Text] [Related]
66. Emergence of concurrent infections with colistin-resistant ESBL-positive Klebsiella pneumoniae and OXA-23-producing Acinetobacter baumannii sensitive to colistin only in a Romanian cardiac intensive care unit.
Timofte D; Dan M; Maciuca IE; Ciucu L; Dabija ER; Guguianu E; Panzaru CV
Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2069-74. PubMed ID: 26239064
[TBL] [Abstract][Full Text] [Related]
67. Distribution, genetic diversity and antimicrobial resistance of clinically important bacteria from the environment of a tertiary hospital in Malaysia.
Phoon HYP; Hussin H; Hussain BM; Lim SY; Woon JJ; Er YX; Thong KL
J Glob Antimicrob Resist; 2018 Sep; 14():132-140. PubMed ID: 29540306
[TBL] [Abstract][Full Text] [Related]
68. T2Bacteria magnetic resonance assay for the rapid detection of ESKAPEc pathogens directly in whole blood.
De Angelis G; Posteraro B; De Carolis E; Menchinelli G; Franceschi F; Tumbarello M; De Pascale G; Spanu T; Sanguinetti M
J Antimicrob Chemother; 2018 Mar; 73(suppl_4):iv20-iv26. PubMed ID: 29608753
[TBL] [Abstract][Full Text] [Related]
69. Infection control interventions affected by resource shortages: impact on the incidence of bacteremias caused by carbapenem-resistant pathogens.
Kousouli E; Zarkotou O; Politi L; Polimeri K; Vrioni G; Themeli-Digalaki K; Tsakris A; Pournaras S
Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):43-50. PubMed ID: 28879405
[TBL] [Abstract][Full Text] [Related]
70. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy.
Zavascki AP; Carvalhaes CG; Picão RC; Gales AC
Expert Rev Anti Infect Ther; 2010 Jan; 8(1):71-93. PubMed ID: 20014903
[TBL] [Abstract][Full Text] [Related]
71. Recent trends in resistance to cell envelope-active antibacterial agents among key bacterial pathogens.
Master RN; Deane J; Opiela C; Sahm DF
Ann N Y Acad Sci; 2013 Jan; 1277():1-7. PubMed ID: 23346857
[TBL] [Abstract][Full Text] [Related]
72. Minocycline and Tigecycline: What Is Their Role in the Treatment of Carbapenem-Resistant Gram-Negative Organisms?
Shankar C; Nabarro LEB; Anandan S; Veeraraghavan B
Microb Drug Resist; 2017 Jun; 23(4):437-446. PubMed ID: 27564414
[TBL] [Abstract][Full Text] [Related]
73. Infection in burn patients in a referral center in Colombia.
Ramirez-Blanco CE; Ramirez-Rivero CE; Diaz-Martinez LA; Sosa-Avila LM
Burns; 2017 May; 43(3):642-653. PubMed ID: 28185802
[TBL] [Abstract][Full Text] [Related]
74. Evaluation of high-resolution melting curve analysis of ligation-mediated real-time PCR, a rapid method for epidemiological typing of ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter Species) pathogens.
Woksepp H; Ryberg A; Billström H; Hällgren A; Nilsson LE; Marklund BI; Olsson-Liljequist B; Schön T
J Clin Microbiol; 2014 Dec; 52(12):4339-42. PubMed ID: 25232168
[TBL] [Abstract][Full Text] [Related]
75. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.
Dowzicky MJ; Park CH
Clin Ther; 2008 Nov; 30(11):2040-50. PubMed ID: 19108792
[TBL] [Abstract][Full Text] [Related]
76. A single-center, six-year evaluation of the role of pulsed-field gel electrophoresis in suspected burn center outbreaks.
Yun HC; Tully CC; Mende K; Castillo M; Murray CK
Burns; 2016 Sep; 42(6):1323-30. PubMed ID: 27180602
[TBL] [Abstract][Full Text] [Related]
77. Confronting multidrug-resistant Acinetobacter baumannii: a review.
Neonakis IK; Spandidos DA; Petinaki E
Int J Antimicrob Agents; 2011 Feb; 37(2):102-9. PubMed ID: 21130607
[TBL] [Abstract][Full Text] [Related]
78. Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015.
Sader HS; Castanheira M; Flamm RK
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28069649
[TBL] [Abstract][Full Text] [Related]
79. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).
De Angelis G; Fiori B; Menchinelli G; D'Inzeo T; Liotti FM; Morandotti GA; Sanguinetti M; Posteraro B; Spanu T
Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1627-1636. PubMed ID: 29948360
[TBL] [Abstract][Full Text] [Related]
80. Prevalence of ESKAPE pathogens in the environment: Antibiotic resistance status, community-acquired infection and risk to human health.
Denissen J; Reyneke B; Waso-Reyneke M; Havenga B; Barnard T; Khan S; Khan W
Int J Hyg Environ Health; 2022 Jul; 244():114006. PubMed ID: 35841823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
